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Objectives of Internship
• Enhance proficiency in cell culture (human fibroblast cells)
• Become familiar with assay and analysis techniques
 Immunofluorescence assays, fluorescence microscopy, DNA microarray analysis
• Apply learned techniques to further bleomycin ground study in preparation for parallel 
in-flight study
• Learn about space travel and science in space from SLSSI lectures
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Background
• Space is a environment filled with radiation
 Trapped protons, Galactic Cosmic Rays (GCRs), Solar Particle Events (SPEs)
• Assess astronaut’s radiation risk
 How cells respond to radiation
 More important for long-term missions and missions outside of Near Earth Orbit (NEO)
• Question: How is DNA repair altered in microgravity compared to on Earth?
 A controlled source of radiation is desired
 Funded by NASA Fundamental Space Biology Program
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Bleomycin
• Chemotherapy antibiotic
• Able to induce DNA double-strand breaks (DSBs) – radiomimetic 
• Controlled source of DNA damage
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γ-H2AX Assay and 53BP1 Assay
• Quantification of DSBs
• Creation of foci as a result of DSBs from ionizing radiation 
• H2AX – histone component variant
 Phosphorylation of serine residue indicates DSB
 Previous study tested high concentrations of bleomycin (0-80 µg/mL) and found little dose 
response (Venkatachalam et. al, 2008)
• 53BP1(p53-binding protein 1): protein involved in DNA repair and tumor suppression
 Indirect quantification of DSBs
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Cell Cycle Markers
• Determine if level of DNA damage correlates to stages of cell cycle
• Cyclin D1 and E: mid-to-late G1 phase
• Cyclin A: high expression S phase, low expression in early G2 phase
• Cyclin B1: G2 phase. Expressed in nucleus in early M phase
• Phosphohistone H3: M phase
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• Identify cell cycle stage that is best to 
study DNA damage and nuclear foci 
production
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Bleomycin Treatment
• Growth of fibroblast cells in six 8-well tissue culture slides
• Once cells were 90% confluent, bleomycin treatment was performed
 0, 0.1, 1, and 10 µg/mL for 3 hours
• Cells fixed with 4% paraformaldehyde
• Immunofluorescence staining:
 1: γ-H2AX and 53BP1
 2: γ-H2AX and Cyclin A (S phase)
 3: γ-H2AX and Cyclin B1 (G2 phase)
 4: γ-H2AX and Phosphohistone H3 (M Phase)
 5: γ-H2AX and Cyclin D1 (G1 phase)
 6: 53BP1 and Cyclin D1 (G1 phase)
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Results: γ-H2AX and 53BP1 Classification
  Classification of cell types:
 Type I: Bright, pannuclear stain
 Type II: Uncountable bright foci or near pannuclear stain
 Type III: Countable foci
 Type IV: (only applies to 53BP1 analysis) γ-H2AX signal present, 
but observation of weak or no 53BP1 signal  
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Results: γ-H2AX and 53BP1 Foci Counts
  Distribution of foci 
counts: unimodal
  One type for all cell with 
countable foci
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53BP1 γ-H2AX
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Results: γ-H2AX and 53BP1 Foci Counts
  Slight dose response for 53BP1, but not for γ-H2AX
  All significant changes except between 0.1 and 1 for γ-H2AX 
Bleomycin: A Study of DNA Damage and the Cell Cycle 12
0
2
4
6
8
10
12
14
16
18
0 0.1 1 10
#
 
o
f
 
F
o
c
i
Bleomycin Dose (µg/mL)
Dose vs. Average Number of Foci
H2AX
53BP1
National Aeronautics and Space Administration
Results: γ-H2AX and 53BP1 Foci Counts
  As dose increases, Type I and II for γ-H2AX increase and Type I for 53BP1 increases
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Results: Cell Cycle Study
  Cyclin D1 : G1 phase
  Almost all cells are Type III
  Dose response observed 
for γ-H2AX foci
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Results: Cell Cycle Study
  Cyclin A : S phase
  Most cells are Type III
  No dose response 
observed, due mainly to 
the high background in the 
control
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DNA Microarray
  Analyzed microarray data from previous microarray samples
 GenePix4000B for data acquisition
 GenePix Pro 7 for data retrieval
 Microsoft Excel and EASE for analysis
 0, 0.1, 1, and 10 (µg/mL)
 Up-regulated or down-regulated
  DNA microarray system:
 Human GE 4x44K v2 Microarray
 ~44,000 transcripts
 Target 27,958 Entrez Gene RNAs
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Significant Genes
  Major categories affected (all concentrations):
 Apoptosis (cell death, programmed cell death, death)
 Regulation of Cell Proliferation
 DNA Repair or Response to DNA 
Damage/Endogenous Stimulus
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Significant Genes
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Significant Genes
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• CDKN1A
 Regulates G1 checkpoint by inhibiting activity of cyclin-CDK4 and cyclin-CDK2
 Involved in p53 pathway in response to DNA damage
• MDM2
 Part of autoregulatory negative feedback loop of the p53 pathway
 Component in complex which links growth factor and DNA damage response 
pathways
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• GADD45A
 Increase in transcription usually follows environmental stresses and will lead to 
activation of the p38/JNK pathway
 Activation of this gene due to DNA damage is mediated by p53 and other pathways
• DDB2
 Required for DNA repair (especially UV-induced DNA repair)
 Ubiquitination of histones H3 and H4 which aids cellular response to DNA damage
Significant Genes
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Conclusions
  53BP1 and γ-H2AX are typically used markers for DNA DSBs caused by ionizing 
radiation, as indicated by colocalization of nuclear foci.  However, similar to UV 
radiation, cells with bleomycin-induced DNA damage generally have more γ-H2AX
foci than 53BP1 foci.
  53BP1 and γ-H2AX have both shown dose dependent characteristics in identifying 
damange-induced foci. 53BP1 may be a better for DSBs because it showed a dose 
response more consistently.
  In terms of the cell cycle, cells in G1 phase tend to have fewer damage-induced foci 
than cells in S phase. 
  In general, an increase in number of genes involved in apoptosis, gene repair, and 
regulation of cellular processes is seen as the dose of bleomycin increases. 
  Based on these data, we established that a concentration of 1 µg/mL should be used 
for the flight study. In addition, cells in the G1 phase should be analyzed for 
comparison to the ground study results.
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Future Directions
  Conduct further gene studies based on DNA microarray data 
including pathway analysis and cluster analysis.
  Test bleomycin treatment for different lengths of time and allow 
specific time intervals for DNA repair to occur following treatment. 
  Complete and analyze remaining cell cycle stains in order to 
conclude that ground and flight analysis should be completed 
based on G1 phase cells. 
  Become a practicing physician and aid the space industry in 
finding countermeasures to mitigate the effects of spaceflight on 
humans.
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